Shawn Tomasello

Shawn Cline Tomasello was the founder of Shawn Tomasello Consulting LLC, founded in 2015, where the title held was Chief Executive Officer in 2015.
Current jobs include Director at Centrexion Therapeutics Corp.
since 2017, Independent Director at 4D Molecular Therapeutics, Inc. since 2020, Director at Geneos Therapeutics, Inc., and Independent Director at Cabaletta Bio, Inc. since 2023.
Former jobs include Chairman at Gamida Cell Ltd. from 2023 to 2024, National Director-Hematology at Genentech, Inc. from 1989 to 2005, Independent Director at Abeona Therapeutics, Inc. in 2020, Non-Executive Director at Oxford BioTherapeutics Ltd., Director at Principia Biopharma, Inc. from 2019 to 2020, Director at Orna Therapeutics, Inc. from 2022 to 2024, Independent Non-Executive Director at Mesoblast Ltd. from 2018 to 2022, Independent Director at Diplomat Pharmacy, Inc. from 2015 to 2020, Independent Director at UroGen Pharma Ltd. from 2018 to 2022, Director at Clementia Pharmaceuticals, Inc. from 2018 to 2019, Independent Director at TCR² Therapeutics, Inc. from 2021 to 2023, Independent Director at AlloVir, Inc., Senior VP, President-Hematology & Oncology at Celgene Corp.
from 2005 to 2014, Chief Commercial Officer at Pharmacyclics LLC from 2014 to 2015, Chief Commercial Officer at Kite Pharma, Inc. from 2015 to 2018, and Trustee at BioNJ, Inc. Education includes an MBA degree from Murray State University (Kentucky) conferred in 1989 and an undergraduate degree from the University of Cincinnati (Ohio) conferred in 1982.